156 related articles for article (PubMed ID: 16427289)
1. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of curcumin analogues.
Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.
Simoni D; Rizzi M; Rondanin R; Baruchello R; Marchetti P; Invidiata FP; Labbozzetta M; Poma P; Carina V; Notarbartolo M; Alaimo A; D'Alessandro N
Bioorg Med Chem Lett; 2008 Jan; 18(2):845-9. PubMed ID: 18039573
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.
Adams BK; Ferstl EM; Davis MC; Herold M; Kurtkaya S; Camalier RF; Hollingshead MG; Kaur G; Sausville EA; Rickles FR; Snyder JP; Liotta DC; Shoji M
Bioorg Med Chem; 2004 Jul; 12(14):3871-83. PubMed ID: 15210154
[TBL] [Abstract][Full Text] [Related]
5. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.
Liang G; Shao L; Wang Y; Zhao C; Chu Y; Xiao J; Zhao Y; Li X; Yang S
Bioorg Med Chem; 2009 Mar; 17(6):2623-31. PubMed ID: 19243951
[TBL] [Abstract][Full Text] [Related]
6. Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.
Labbozzetta M; Baruchello R; Marchetti P; Gueli MC; Poma P; Notarbartolo M; Simoni D; D'Alessandro N
Chem Biol Interact; 2009 Sep; 181(1):29-36. PubMed ID: 19539615
[TBL] [Abstract][Full Text] [Related]
7. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits cell motility and alters microfilament organization and function in prostate cancer cells.
Holy J
Cell Motil Cytoskeleton; 2004 Aug; 58(4):253-68. PubMed ID: 15236356
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells.
Valentini A; Conforti F; Crispini A; De Martino A; Condello R; Stellitano C; Rotilio G; Ghedini M; Federici G; Bernardini S; Pucci D
J Med Chem; 2009 Jan; 52(2):484-91. PubMed ID: 19113979
[TBL] [Abstract][Full Text] [Related]
12. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.
Lin L; Shi Q; Nyarko AK; Bastow KF; Wu CC; Su CY; Shih CC; Lee KH
J Med Chem; 2006 Jun; 49(13):3963-72. PubMed ID: 16789753
[TBL] [Abstract][Full Text] [Related]
13. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.
Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH
J Androl; 2008; 29(6):661-8. PubMed ID: 18676361
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and its analogues: potential anticancer agents.
Agrawal DK; Mishra PK
Med Res Rev; 2010 Sep; 30(5):818-60. PubMed ID: 20027668
[TBL] [Abstract][Full Text] [Related]
15. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary evaluation of curcumin analogues as cytotoxic agents.
Zhang Q; Zhong Y; Yan LN; Sun X; Gong T; Zhang ZR
Bioorg Med Chem Lett; 2011 Feb; 21(3):1010-4. PubMed ID: 21215629
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.
Vik A; Hedner E; Charnock C; Tangen LW; Samuelsen Ø; Larsson R; Bohlin L; Gundersen LL
Bioorg Med Chem; 2007 Jun; 15(12):4016-37. PubMed ID: 17442577
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of curcumin-related compounds for anticancer activity.
Wei X; Du ZY; Zheng X; Cui XX; Conney AH; Zhang K
Eur J Med Chem; 2012 Jul; 53():235-45. PubMed ID: 22551677
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of polyhydroxycurcuminoids.
Venkateswarlu S; Ramachandra MS; Subbaraju GV
Bioorg Med Chem; 2005 Dec; 13(23):6374-80. PubMed ID: 16112582
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
